Cite

HARVARD Citation

    Das, J. et al. (2021). Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis. Multiple sclerosis. pp. 1198-1204. [Online]. 
  
Back to record